Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$132.92
+1.6%
$130.21
$99.71
$141.23
$230.53B0.86.13 million shs9.80 million shs
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
$11.52
+0.7%
$11.68
$11.01
$13.13
N/AN/A104,810 shs168,141 shs
RSY
Rsi International Systems
C$0.09
+∞
C$0.09
C$0.08
C$0.12
C$3.30MN/A35,390 shs4,000 shs
VIQ Solutions Inc. stock logo
VQS
VIQ Solutions
$0.22
$0.11
$0.76
$5.78M0.05867,861 shs3.00 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+1.50%+3.12%+0.62%+4.10%+25.05%
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
+0.70%+1.77%-2.42%-4.99%-2.00%
RSY
Rsi International Systems
0.00%0.00%0.00%0.00%0.00%
VIQ Solutions Inc. stock logo
VQS
VIQ Solutions
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.8987 of 5 stars
2.44.04.24.53.42.52.5
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
N/AN/AN/AN/AN/AN/AN/AN/A
RSY
Rsi International Systems
N/AN/AN/AN/AN/AN/AN/AN/A
VIQ Solutions Inc. stock logo
VQS
VIQ Solutions
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.84
Moderate Buy$142.597.27% Upside
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
0.00
N/AN/AN/A
RSY
Rsi International Systems
0.00
N/AN/AN/A
VIQ Solutions Inc. stock logo
VQS
VIQ Solutions
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest VQS, ABT, NXJ, and RSY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$133.00 ➝ $145.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$132.00 ➝ $142.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$140.00 ➝ $145.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$117.00 ➝ $127.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$136.00 ➝ $147.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$158.00 ➝ $159.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $145.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$135.00 ➝ $137.00
3/10/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$133.00 ➝ $150.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $160.00
(Data available from 5/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.50$5.72 per share23.22$22.36 per share5.94
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
$37.58MN/AN/AN/AN/AN/A
RSY
Rsi International Systems
C$4.18M0.79C$0.15 per share0.61C$0.14 per share0.63
VIQ Solutions Inc. stock logo
VQS
VIQ Solutions
$45.84M0.00N/AN/A$0.45 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.7117.3823.202.5231.95%20.74%11.19%7/17/2025 (Estimated)
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
N/AN/A0.00N/AN/AN/AN/A5/5/2025 (Estimated)
RSY
Rsi International Systems
N/AC$0.130.69N/AN/AN/AN/AN/A
VIQ Solutions Inc. stock logo
VQS
VIQ Solutions
-$8.71M-$0.33N/AN/AN/A-24.72%-69.63%-29.13%N/A

Latest VQS, ABT, NXJ, and RSY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/16/2025Q1 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07$1.09+$0.02$0.76$10.38 billion$10.36 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.78%+7.17%30.61%54 Years
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
$0.756.51%N/AN/AN/A
RSY
Rsi International Systems
N/AN/AN/AN/AN/A
VIQ Solutions Inc. stock logo
VQS
VIQ Solutions
N/AN/AN/AN/AN/A

Latest VQS, ABT, NXJ, and RSY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/2/2025
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
monthly$0.07858.2%5/15/20255/15/20256/2/2025
2/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.75%4/15/20254/15/20255/15/2025
4/3/2025
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
monthly$0.07857.9%4/15/20254/15/20255/1/2025
3/3/2025
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
Monthly$0.07857.68%3/14/20253/14/20254/1/2025
2/3/2025
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
Monthly$0.07857.76%2/14/20252/14/20253/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.14
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
N/AN/AN/A
RSY
Rsi International Systems
9.02
15.35
15.24
VIQ Solutions Inc. stock logo
VQS
VIQ Solutions
0.84
0.90
0.89
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.73 billionOptionable
Nuveen New Jersey Quality Municipal Income Fund stock logo
NXJ
Nuveen New Jersey Quality Municipal Income Fund
2,340N/AN/ANot Optionable
RSY
Rsi International Systems
N/A36.69 millionN/ANot Optionable
VIQ Solutions Inc. stock logo
VQS
VIQ Solutions
N/A40.73 million31.40 millionNot Optionable

Recent News About These Companies

VIQ Solutions to Announce Q3 2024 Financial Results
VIQ Solutions reports Q4 results
Closing Bell: Viq Solutions Inc up on Thursday (VQS)
Closing Bell: Viq Solutions Inc flat on Monday (VQS)
Closing Bell: Viq Solutions Inc up on Monday (VQS)
Closing Bell: Viq Solutions Inc up on Tuesday (VQS)
VIQ Solutions stock climbs on CapturePro Mobile release
Closing Bell: Viq Solutions Inc down on Monday (VQS)
Closing Bell: Viq Solutions Inc flat on Thursday (VQS)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$132.92 +2.04 (+1.56%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$133.07 +0.15 (+0.11%)
As of 05/2/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Nuveen New Jersey Quality Municipal Income Fund stock logo

Nuveen New Jersey Quality Municipal Income Fund NYSE:NXJ

$11.52 +0.08 (+0.66%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$11.52 0.00 (0.00%)
As of 05/2/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nuveen New Jersey Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New Jersey. The fund invests in undervalued municipal securities and other related investments that are, exempt from regular federal and New Jersey income taxes that are rated Baa or BBB or better. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's (S&P) New Jersey Municipal Bond Index. The fund was formerly known as Nuveen New Jersey Dividend Advantage Municipal Fund. Nuveen New Jersey Quality Municipal Income Fund was formed on June 1, 1999 and is domiciled in the United States.

Rsi International Systems CVE:RSY

C$0.09 +0.09 (+∞)
As of 08/12/2019

RSI International Systems Inc., together with its subsidiary, provides an integrated Web-based real-time reservation and property management system (PMS) in Canada, the United States, and internationally. The company offers RoomKeyPMS, a Web-based PMS that includes a real time online reservation booking engine. It serves the hospitality industry, including independent single-property, franchise, and multi-property hotels; and hotel management companies. RSI International Systems Inc. was founded in 1978 and is headquartered in Vancouver, Canada.

VIQ Solutions stock logo

VIQ Solutions NASDAQ:VQS

VIQ Solutions Inc. operates as a technology and service platform provider for digital evidence capture, retrieval, and content management in Australia, the United States, the United Kingdom, Canada, and internationally. It operates through two segments, Technology and Related Revenue, and Technology Services. The Technology and Related Revenue segment develops, distributes, and licenses computer-based digital solutions based on its technology. The Technology Services segment provides recording and transcription services. The company offers CapturePro that securely speeds the capture, creation, and management of large volumes of information, as well as preserves and secures the spoken word and video image, and delivers data; MobileMic Pro for capturing and managing incident reports, recorded statements, case notes, and other vital information; NetScribe, a comprehensive transcription creation and management platform that consolidates, accelerates, and optimizes workflows; aiAssist, a multi-tenant workflow and analysis platform to manage, convert, and analyze large volumes of audio and visual content; FirstDraft that converts audio files to text to provide access to interviews, testimonies, recorded calls, and dictations; and AccessPoint, a secure online portal that simplify court recording management, playback, and distribution. It also provides Carbon, a media-centric, and web-based platform that uses automatic speech-to-text; and Lexel, a cloud-based legal evidence management solution. In addition, the company provides legal, criminal justice, insurance, government, medical, corporate finance, media, and transcription services. VIQ Solutions Inc. was incorporated in 2004 and is headquartered in Mississauga, Canada.